Notes in F. Chemotherapeutic and Other Pharmaceutical Agents

To Subscribe, use this Key

entries per page

Search:

Status	Last Update	Fields
Published	08/30/2023	Cemiplimab (Libtayo) MOA, indications, AEs, RR, Dosing, Precautions No pregs for at least 5 mo since last dose and multiple myeloma pts caution
Published	08/30/2023	Anti-CTLA-4: • Anti-PD-1: • Anti-PD ligand 1 antibody:
Published	08/30/2023	What immune checkpoint inhibitors are approved for advanced melanoma?
Published	08/30/2023	In ???, combination therapy with nivolumab and ipilimumab results in higher overall survival (OS) compared with ipilimumab alone
Published	08/30/2023	? and ? have each shown superior OS, with bettersafety profile than ipilimumab
Published	08/30/2023	? and ? are immune checkpoint inhibitors approved for MCC
Published	08/30/2023	NCCN recommends ?, ?, ? as first-linetherapies for advanced MCC before chemotherapy
Published	08/30/2023	? is the only approved CPI for cSCC
Published	08/30/2023	Capecitabine MOA, indications, AEs, RR, dosing, labs, interactions, c/I
Published	08/30/2023	Cetuximab MOA, Indications, AEs, Dosing, Precautions
Status	Last Update	Fields

Showing 1 to 10 of 24 entries